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Abstract Nitric oxide and peroxynitrite (generated by the 
reaction of nitric oxide with the superoxide anion) may both be 
mediators of [$-ceH damage in early insulin-dependent diabetes 
mellitus. We observed that acute exposure of primary cultured 
human pancreatic islets to peroxynitrite results in a significant 
decrease in glucose oxidation and islet retrieval. DNA strand 
breaks in single human and rat islet cells are detectable after 
acute peroxynitrite xposure, followed by a decrease in islet cell 
survival after 1 h and 24 h. Cell death appeared to occur via a 
toxic cell death mechanism (necrosis) rather than apoptosis, as 
suggested by vital staining and ultrastructural evidence of early 
membrane and organelle degradation, mitochondrial swelling and 
loss of matrix. This study demonstrates for the first time that 
cultured human pancreatic islets are susceptible to the noxious 
effects of peroxynitrite. 
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I. Introduction 
Destruction of the pancreatic beta cells in insulin-dependent 
diabetes mellitus ( IDDM) occurs as part of an autoimmune 
mediated assault [1], During an immune response or an in- 
flammatory reaction, activated macrophages are present with- 
in the vicinity of the ]3-cell [2]. It is well documented that 
activated macrophages can produce both nitric oxide and a 
mixture of oxygen radicals, including the superoxide anion [3]. 
The superoxide anion is also produced as a result of normal 
cellular metabolism and from the oxidation of endogenous 
biomolecules. Nitric oxide can be formed within the pancre- 
atic ]3-cells following cytokine induction of nitric oxide 
synthase (reviewed in [4]). Several studies into the mechanisms 
involved in cytokine-induced 13-cell functional inhibition and 
cytotoxicity have revealed a fundamental role for nitric oxide 
and oxygen radicals (for reviews see [5,6]). In addition to the 
individual toxic effects of these radicals, nitric oxide reacts 
with a very high rate constant with superoxide to form the 
peroxynitrite anion (ONOO-) ,  that will be protonated to per- 
oxynitrite, a potent oxidant, during physiological conditions 
[7]. Recently, several potential sites for peroxynitrite-mediated 
cytotoxicity in cells have been revealed, many of which were 
previously thought to be sites for nitric oxide-mediated cyto- 
toxicity (for review see [8]). 
We have previously identified a major species difference in 
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the susceptibility to pancreatic ~-cell injury, with human islets 
being less susceptible to several different assaults than islets 
from rat or mouse [9-11]. More recently, we observed that 
human islets are more resistant than rodent islets to nitric 
oxide-induced DNA damage [12], although nitric oxide itself 
can decrease human islet survival [11]. The aim of the present 
study was to examine whether primary cultured human islets 
are susceptible to the deleterious effects of peroxynitrite or its 
decomposition products, and to compare the susceptibility of 
human and rodent islets to peroxynitrite xposure. 
2. Materials and methods 
2.1. Materials 
Chemicals were purchased from the following sources: culture me- 
dium RPMI-1640, foetal calf serum, penicillin and streptomycin, 
Hank's balanced salt solution, trypsin, BSA and agarose from Sigma 
Chemical Co. (St. Louis, MO, USA); D-[U-14C]glucose (55 ~tCi/mmol/ 
1) from Amersham International (Amersham, UK); collagenase from 
Clostridium hBtolyticum from Boehringer-Mannheim (Mannheim, 
Germany). All other chemicals of analytical grade were obtained 
from E. Merck (Darmstadt, Germany) or Sigma Chemicals. 
Peroxynitrite used in the experiments was purchased from Alexis 
Corp. (San Diego, CA, USA) and stored in alkaline solution at 
-70°C for several weeks. When using this preparation, the peroxyni- 
trite concentration was checked spectrophotometrically t 302 nm 
before each experimental procedure [13]. In the experiments a small 
volume (17 btl) of concentrated peroxynitrite (10 mM in 1 M NaOH), 
was added to islets placed in 0.8 ml Krebs Ringer bicarbonate buffer 
(KRBH; pH 7.4) for 10 min and the culture dish was swirled to 
distribute the peroxynitrite. The amount of peroxynitrite added did 
not affect the pH of the KRBH solution (data not shown). A negative 
control containing decomposed peroxynitrite was prepared from the 
same stock as the active form, and it was used throughout the experi- 
ments at the same concentration asperoxynitrite, to exclude the pos- 
sibility that other reactants were toxic to the islets. The negative con- 
trol contained the same concentrations of hydrogen peroxide, nitrite 
and sodium chloride as the peroxynitrite preparation, but did not 
have any absorbance at 302 nm under alkaline conditions. 
2.2. Islet isolation, culture and test agent treatment 
Pancreatic islets were isolated by collagenase digestion from adult 
male Sprague-Dawley rats bred in a local colony (Biomedical Centre, 
Uppsala, Sweden). The islets were maintained free-floating in culture 
medium for 24  days at 37°C [14] before treatment with the test 
agents. The culture medium, which was changed every 48 h, was 
RPMI 1640 containing 10% foetal calf serum, benzylpenicillin (60 
mg/ml), streptomycin (0.1 mg) and 11.1 mM glucose. 
Islets from 9 human heart-beating organ donors were isolated at the 
Central Unit of the I]-Cell Transplant (Vrije Universiteit Brussel, 
Brussels, Belgium). The mean age of the donors was 43.5 +4.7 years. 
Aliquots of the islet-enriched fraction were examined routinely by 
electron microscopy, which indicated less than 6% dead cells or exo- 
crine cells in all preparations. Light microscopical examination of 
immunoeytoehemically stained islets was carried out routinely on all 
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Table 1 
Effect of peroxynitrite on human and rat islet glucose oxidation immediately (acute) or 24 h after exposure, and on islet retrieval after 24 h in 
culture 
Species Treatment Glucose oxidation Islet retrieval (%) 
(pmol/20 islets per 1.5 h) 
Human Acute 
Control 127.1 _+ 15,8 (6) 
Peroxynitrite 0.2 mM 88.7_+ 17,8 (6) 
Peroxynitrite 1.0 mM 57.6 _+ 11,0 (6) ~' 
Neg control 0.2 mM 129.9 _+ 14,8 (5) 
Rat 
24 h 
Control 91.6 -+ 13.1 (5) Control 96.9 _+ 1.8 (4) 
Peroxynitrite 0.2 mM 36.4 _+ 11.5 (5p Peroxynitrite 0.2 mM 83.8 + 4.0 (4p 
Peroxynitrite 1.0 mM 2.2 -+ 1.6 (5) b Peroxynitrite 1.0 mM 70.8 -+ 5.5 (4) b 
Neg control 0.2 mM 93.8 _+ 13.9 (5) Neg control 0.2 mM 96.3 _+ 2.0 (3) 
(pmol/10 islets per 1.5 h) 
Acute 
Control 846.4_+ 85.1 (5) 
Peroxynitrite 0.2 mM 504.5 _+ 87.5 (5) b 
Neg control 0.2 mM 750.5 + 167.3 (5) 
24 h 
Control 716.3 + 137.2 (5) Control 99.3 -+ 0.7 (7) 
Peroxynitrite 0.2 mM 400.1 -+ 104.6 (5) b Peroxynitrite 0.2 mM 87.6 + 2.9 (7) b 
Neg control 0.2 mM 708.8 _+ 192.7 (5) Neg control 0.2 mM 95.4 + 2.7 (7) 
Groups of islets were exposed for 10 rain to peroxynitrite and either studied immediately (Acute) or following a subsequent 24 h in culture. Control 
islets were exposed to vehicle only while the negative (Neg) control contained ecomposed peroxynitrite solution. For the glucose oxidation studies 
the islets were incubated in triplicate groups of 20 (human) or 10 (rat) for 90 min in KRBH supplemented with D-[U-vlC]glucose and 16.7 mM 
glucose. After 24 h the number of islets remaining in culture was counted again (islet retrieval, expressed as a % of the original number of islets 
placed in culture). The results are means_+ S.E.M. of the number of separate xperiments indicated in parentheses. ~p < 0.05 and ~'p < 0.01 when 
compared to control islets; paired t-test. 
preparations and indicated the prevalence of insulin- and glucagon- 
positive cells to be 51.2+ 3.5 and 13.6_+ 1.6%, respectively, n =9. The 
isolation and culture conditions for human pancreatic islets have been 
described previously [15]. The islets were subsequently sent by air to 
Uppsala, where they were cultured in RPMI 1640 medium containing 
10% FCS and 5.6 mM glucose. We have previously shown that func- 
tional preservation in RPMI 1640 medium is optimal at 5.6 mM 
glucose for human islets [15] and at 11 mM for rodent islets [10,14]. 
After 5-6 days in culture, groups of human islets were acutely exposed 
to peroxynitrite (0.2 or 1.0 mM) for 10 min and then functional and 
survival studies were performed either immediately after (acute) or 
following a subsequent period of 24 h in culture without the radical 
(see below). 
2.3. Islet glucose oxidation and retrieval studies 
Following exposure to peroxynitrite, the islets were rinsed with 
KRBH and islet glucose oxidation rates were determined either 
acutely or after a subsequent 24 h in culture. For this purpose, tripli- 
cate groups of 20 human or 10 rat islets were used. This higher 
number of human islets was selected based on our previous observa- 
tions that glucose oxidation is much lower in human than in rodent 
islets [10]. The islets were transferred to glass vials containing KRBH 
supplemented with o-[U-14C]glucose and non-radioactive glucose to a 
final concentration of 16.7 mM glucose for 90 min. Islet glucose 
oxidation was measured as previously described [16]. Islet retrieval 
was examined in islets treated with vehicle (control), peroxynitrite 
or negative control for 10 min and then cultured for 24 h. Retrieval 
was expressed as a % of the original number of islets placed in culture. 
2.4. Measurement of DNA damage 
Islets were treated with vehicle (control), peroxynitrite or negative 
control and then rinsed in KRBH before retrieval for DNA damage. 
DNA strand breakage was quantified using the alkaline version of the 
comet assay (single cell gel electrophoresis) (for recent review on this 
technique see [17]), performed as previously described for islet tissue 
[18], with the modifications described below. After the appropriate 
treatments, groups of 100 islets were rinsed in Hanks buffered saline 
solution (HBSS) and then gently dispersed into single cells with tryp- 
sin. Islet single cells (approx. 5x104 per slide) were embedded in 
duplicate, on top of a 0.6% low melting point agar base layer (on 
slides precoated with 0.6% agar) and placed in an incubator at 37°C 
for 1 h, to allow repair of putative trypsin-induced damage. Slides 
were then placed in lysis solution (2.5 M NaC1, 100 rnM EDTA, 10 
mM Tris, 1% Na sarcosinate, 10% DMSO and 1% Triton) for 1 h to 
lyse away non-nuclear cell components and then placed in electro- 
phoresis buffer (0.3 M NaOH, 1 mM EDTA) for 40 rain. This treat- 
ment allows the DNA containing strand breaks to unwind, and the 
DNA fragments to move towards the anode, in a comet tail, during 
electrophoresis carried out at 20 V and 300 mA for 24 min. The slides 
were then neutralised and stained with ethidium bromide (20 gg/ml). 
The length and the intensity of the fragmented DNA in the tail region 
is proportional to the extent or severity of DNA damage [17]. DNA 
damage was evaluated using two parameters: the tail length, which 
can be defined as the distance fragmented DNA has migrated follow- 
ing electrophoresis, and the tail moment, which additionally takes into 
account he proportion of DNA in the fragmented or damaged tail/ 
comet region. DNA damage was directly quantified using a fluores- 
cent image analysis system [19]. Briefly, the slides were examined at 
500 x magnification in a fluorescence microscope (excitation filter, 
515-560 nm; barrier filter, 590 nm) attached to a black and white 
CCD video camera (Model ICD-42E, type F/L. Ikegami Tsushinki 
Co., Tokyo, Japan), connected to a computer-based image analysis 
system. The image analysis program Aequitas (IA version 1.3. DDL 
Ltd., Cambridge, UK), with its special application for the 'comet 
assay' AutoCell (version 8A, Reppalon AB, H~igersten, Sweden), 
was used when evaluating the degree of DNA damage in individual 
cells. Details on the program and performance of the image analysis 
system were described previously [19]. 
2.5. Assessment of islet cell survival 
After peroxynitrite treatment intact islets were rinsed in HBSS and 
dispersed with trypsin into single cells. The cells were stained with 
either trypan blue solution (0.4%) or with the DNA binding fluoro- 
phore propidium iodide (50 /,tg/ml). Trypan blue (TB) staining was 
used to evaluate loss of membrane integrity, associated with cell ne- 
crosis [20] and propidium iodide (PI) to indicate DNA fragmentation 
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and chromatin condensation associated with late apoptosis [21] or 
necrosis. Cell survival was quantified by counting the total number 
of cells and the percentage TB or PI positive cells examined at the 
appropriate ime points. 
2.6. Electron microscopic examination fperoxynitrite exposed human 
islets 
Following exposure to peroxynitrite for 10 min, 40~60 islets were 
rinsed and placed in culture in RPMI-1640 medium containing 10% 
FCS and 5.6 mM glucose for 6 or 24 h. After this the islets were 
rinsed in KRBH and fixed with 2.5% glutardialdehyde in 0.1 M ca- 
codylate buffer, pH 7.4. The pellets were postfixed in 1% aqueous 
osmium tetroxide, stained 'en bloc' with 1% uranyl acetate, dehy- 
drated in increasing ethanol concentrations and embedded in Spurr 
resin. Ultrathin sections were prepared and examined with a Zeiss 
EMI09 transmission electron microscope. At least 50 cells were 
counted (by an observer unaware of the identity of the samples) to 
determine the percentage of cells with either necrotic or apoptotic 
degradative changes. 
2. 7. Statistical nalysis 
Data are presented as means_ +S.E.M., and statistical differences 
between groups were determined using Student's paired or unpaired 
t-test, as appropriate. In all experiments, each islet preparation (islets 
obtained from one donor) was considered as one individual observa- 
tion~ even when experiments were performed induplicate or triplicate. 
3. Results 
3.1. Effect of peroxynitrite on islet glucose oxidation and islet 
retrieval 
Treatment of human islets with peroxynitrite at0.2 mM did 
not significantly affect glucose oxidation acutely, but after 24 
h in culture glucose oxidation was decreased by 60% (Table 
1). When human islets were treated with 1.0 mM peroxynitrite 
glucose oxidation was markedly decreased (60 95% decrease) 
both acutely and after a 24 h culture period (Table 1). In rat 
islets treatment with 0.2 mM peroxynitrite was sufficient to 
inhibit glucose oxidation both acutely and after a 24 h culture 
period. Exposure to 1.0 mM peroxynitrite induced widespread 
destruction of rat islets, preventing further functional studies 
at that concentration (data not shown). Islet retrieval data 
revealed that peroxynitrite xposure decreased the number 
of both human and rat islets remaining in culture after 24 
h. The negative control when applied at 0.2 mM did not 
adversely affect either glucose oxidation or islet retrieval, 
although a higher dose (1.0 mM) was found to partly inhibit 
glucose oxidation in rat islets (data not shown). 
3.2. Peroxynitrite induced DNA strand breakage 
A 10 min exposure of human islets to peroxynitrite caused 
extensive DNA strand breakage in individual islet cells, as 
indicated both by an increase in the overall mean comet 
length (Fig. 1) and by an increase in the tail moment from 
164.0+ 18.6 (control) to 397.5 +80.8 (0.2 mM peroxynitrite; 
p < 0.05 versus control using Student's unpaired t-test). Mean 
comet length (Fig. 1) and tail moment 188.1 + 25.5 (n = 5 6) in 
the negative control were similar to values observed in the 
control. In rat islets there was also an increase in the overall 
mean comet length (Fig. 1) and an increase in the tail moment 
with peroxynitrite treatment (data not shown). 
3.3. Cell survival following peroxynitrite xposure 
A decrease in cell viability, as demonstrated bythe inability 
to exclude trypan blue, was observed in human islet cells al- 
ready after a 10 min exposure to either 0.2 or 1.0 mM per- 
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oxynitrite (Fig. 2A). At this time point there was no effect of 
peroxynitrite on propidium iodide staining. After a subse- 
quent period of 24 h (Fig. 2B) a decrease in cell viability 
was observed after both 0.2 and 1.0 mM peroxynitrite treat- 
ment, as judged by both trypan blue and propidium iodide 
staining. The survival of rodent islets was affected both 
acutely and after a 24 h recovery period according to trypan 
blue staining (Fig. 2C,D), but there was no increase in propi- 
dium iodide staining at either time points in rat islets. In both 
the human and rat experiments he negative control did not 
decrease cell survival. As a whole, these results suggest hat 
peroxynitrite induced early cell necrosis. 
3.4. Effect of peroxynitrite on ultrastructure of human islets 
Electron microscopic analysis of human islets revealed well 
preserved control islets, while peroxynitrite-treated islets had a 
high percentage of necrotic cells (Fig. 3). Necrosis did not 
appear to be restricted to a particular type of islet cell, as it 
was observed in all islet cell types and also in the small frac- 
tion of contaminating on-endocrine c lls. In islets studied 6 h 
after exposure to 0.2 mM peroxynitrite, the percentage of 
necrotic cells ranged between 5 and 50% (average 35%), 
whereas with 1 mM peroxynitrite an average of 95% of cells 
were necrotic (data based on 3 separate human islet prepara- 
tions). Necrotic characteristics included membrane degrada- 
tion, 'extraction' of cytoplasmic and nucleoplasmic compo- 
nents, and degradation of organelles. With 0.2 mM 
peroxynitrite treatment, where relatively less severe degrada- 
tion occurred, we noted the frequent occurrence of mitochon- 
drial swelling and loss of mitochondrial matrix. Cells with 
characteristics of apoptotic ell death, such as nuclear con- 
densations and fragmentation, were very rarely observed in 
peroxynitrite treated cells (similar to controls and negative 
control). The percentage of dead cells in control cultures (no 
peroxynitrite) and in cultures treated with the negative control 
was < 1%. In islets retrieved 24 h after peroxynitrite exposure, 
the mean percentage of necrotic ells was 77% (50-100%) at 
1 mM and 10% at 0.2 mM (control and negative control, 
< 1%). This apparently reduced fraction of necrotic ells at 
24 h, compared to 6 h, may be explained by a selective loss of 
completely degraded cells from whole islets during the culture 
period. This is confirmed by first the 'cloudy' appearance 
(macroscopically) after the 24 h culture of peroxynitrite-treat- 
ed islets, with tissue debris in the medium; and second, by a 
clear reduction in the total number of cells in the pellets. 
Again, there were very few cells showing signals of apoptosis 
after 24 h in all studied groups. 
4. Discussion 
The main question addressed by this paper is whether hu- 
man pancreatic islets are susceptible to peroxynitrite-induced 
cell dysfunction and death. Peroxynitrite caused a progressive 
decrease in glucose oxidation, which was accompanied by an 
early induction of DNA strand breaks. Peroxynitrite toxicity 
to pancreatic islets was confirmed both by ultrastructural 
signs of membrane and organelle damage, leading to necrotic 
cell death, and by vital staining techniques (trypan blue and 
propidium iodide), indicating death of more than 50% of islet 
cells 24 h after an acute exposure to 0.2 1.0 mM peroxyni- 
trite. The fact that a negative control containing decomposed 
peroxynitrite solution i.e. hydrogen peroxide, nitrite, nitrate 
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Fig. 1. DNA damage following treatment of human (top graph) and rat (lower graph) islets with vehicle only (control), peroxynitrite (0.2 mM) 
or negative control (0.2 mM) for 10 min. Results represent the overall mean comet length (intact head diameter and tail length) +_ S.E.M. 
from 5-6 human (total of 320 nucleoids analysed) and 3 rat (total of 146 nucleoids analysed) separate xperiments. The line represents the 
average nuclear diameter of the head/intact DNA region, whereas the area above the line represents the tail region or damaged/fragmented 
DNA. **p < 0.001 versus control, by Students unpaired t-test. 
and sodium chloride, did not affect human islet function or 
survival, suggests that peroxynitrite (or its reactive decompo- 
sition intermediates) i  the main toxic effector molecule. 
We have previously observed that human pancreatic islets 
are less susceptible than rat or mouse pancreatic islets to the 
damaging effects of cytokines [9], nitric oxide donors [10,11], 
streptozotocin [10], alloxan [10], cycasin [22] and hydrogen 
peroxide [23]. Thus, it is noteworthy that in the present series 
of experiments peroxynitrite induced similar damage to hu- 
man and rat pancreatic islets, as judged by a similar decrease 
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Fig. 2. Cell survival in human and rat islets following exposure to vehicle only, peroxynitrite (0.2 mM) or negative control (0.2 mM). Black 
panels represent data obtained using the trypan blue exclusion test and grey panels represent results obtained with propidium iodide staining. 
The top two graphs show data from 5 separate human islet cell preparations: (A) acute data; (B) data obtained after 24 h in culture. The low- 
er two graphs show rat islet cell data from 6 individual experiments: (C) acute data; (D) 24 h data. *p<0.05, **p<0.01 and ***p <0.001 
versus control, using Students unpaired t-test. 
in islet glucose oxidation and islet retrieval, and similar levels 
of DNA strand breakage. Indeed, to our knowledge, peroxy- 
nitrite is the first toxic agent to which human islets are as 
sensitive as rat islets. This, and the fact that both primary 
cultured human and rat islets seem to be more sensitive to 
peroxynitrite-induced cell dysfunction and death than other 
primary cultured cells (such as human peripheral blood mono- 
nuclear cells and human umbilical vein endothelial cells [24]), 
reinforce a possible role for this potent oxidant as an inflam- 
matory mediator of human [3-cell destruction. 
Human islets express larger amounts of the heat shock pro- 
tein 70 and possess higher activities of the free radical scaven- 
get enzymes manganese superoxide dismutase (SOD) and cat- 
alase than rodents islets [23]. This may at least in part explain 
the decreased susceptibility of human islets to the different 
toxic agents listed above (reviewed in [25]). However, the pres- 
ent data showing similar susceptibility of human and rodent 
islets to peroxynitrite suggest hat higher amounts of these 
'defence' proteins are not sufficient o protect human islets 
against this reactive species. Peroxynitrite is formed by the 
interaction of nitric oxide with superoxide [7], and there is 
data suggesting that human pancreatic islets exposed in vitro 
to cytokines generate both these radicals [26,9,27]. Consider- 
ing the high activity of SOD in human islets [23], it can be 
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Fig. 3. Electron microscopy of human islets examined 24 h after an initial l0 min exposure to vehicle (control) or peroxynitrite (0.2 raM). 
(A) Islets exposed to vehicle only (control), showing well preserved and normal appearing organelles and insulin secretory granules. Magnifica- 
tion 4000x ; (B) islets exposed to 0.2 mM peroxynitrite for 10 min, showing generalised signals of ~-cell necrosis (degradation of membrane 
and organelles). Note also a necrotic ~-cell in the centre of the picture. Magnification 2800 x. 
argued that the enzyme will remove superoxide and prevent 
peroxynitrite formation. However, the rate constant for the 
reaction of the superoxide anion with nitric oxide is consider- 
ably higher than that for superoxide removal by SOD [28], 
increasing the possibility for generation of peroxynitrite in 
vivo. Indeed, to prevent effectively peroxynitrite formation 
SOD must be present in sufficiently greater amounts than 
nitric oxide and must be close to the site of interaction be- 
tween nitric oxide and superoxide. 
Nitric oxide reacts with superoxide to form the peroxyni- 
trite anion, which is stable in alkaline solution but rapidly 
decays to form the protonated peroxynitrous acid which sub- 
sequently decomposes to form several intermediate reaction 
products such as the nitronium ion, nitrogen dioxide and 
either the hydroxyl radical or a 'hydroxyl radical-like inter- 
mediate'. The exact nature of the cytotoxic peroxynitrite re- 
active species is a matter for debate but the early decomposi- 
tion products may each have varying potencies as toxic 
intermediates [29]. The production of peroxynitrite has been 
implicated in many pathological conditions, such as athero- 
sclerosis, acute endotoxemia nd neurological disorders (re- 
viewed in [8]). Peroxynitrite causes hydroxylation and nitra- 
tion of aromatic amino acids, such as tyrosine, leading to the 
in vivo formation of nitrotyrosine. Increased nitrotyrosine l v- 
els have been found both in lung sections of patients with 
lung injury and in the lungs of animals exposed to hypoxia 
[30]. The formation of peroxynitrite may also be involved in 
autoimmune diseases, as suggested by the observations that 
blood serum and synovial fluid from patients with rheumatoid 
arthritis contain 3-nitrotryosine [31] and that nitrotyrosine is
increased in kidney proteins in a mouse model of arthritis and 
glomerulonephritis [32]. Furthermore, a role for peroxynitrite 
produced from activated macrophages has been suggested in 
active inflammatory processes uch as chronic human renal 
allograft rejection [33]. 
The ultimate mechanism(s) by which peroxynitrite l ads to 
~-cell dysfunction and death remains to be clarified. However, 
our data suggest hat the radical induces an early impairment 
in glucose oxidation, which is paralleled by DNA damage. It 
has previously been reported that peroxynitrite decreases the 
activity of the Krebs cycle enzyme aconitase [34,35] which 
may contribute to the observed ecrease in glucose metabo- 
lism. Moreover, peroxynitrite reacts with guanine to form 8- 
nitroguanine [36] and causes DNA strand breaks in islet cells 
(present data) and in the macrophage cell line RAW264.7, 
where it was found that peroxynitrite causes oxidative DNA 
damage [37]. It is therefore conceivable that peroxynitrite-in- 
duced DNA strand breakage may lead to poly ADP-ribose 
synthetase (PARP) activation and NAD consumption. A re- 
duction in NAD may contribute to a further decrease in islet 
glucose metabolism and ATP generation and ultimately insu- 
lin biosynthesis and release. This, together with other poten- 
tial direct effects of the oxidant, may induce overwhelming cell 
damage, leading to the presently observed early ~-cell necro- 
sis. However, it cannot be excluded that prolonged in vivo 
exposure of [3-cells to low concentrations of peroxynitrite 
and/or other radicals may lead to apoptosis. Indeed, data 
obtained from different cell types [24,38] suggest hat both 
nitric oxide and peroxynitrite may lead to either necrosis or 
apoptosis, depending on the intensity and duration of expo- 
sure to these agents. 
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